CHildhood Allergy and tolerance: bioMarkers and Predictors

CHildhood Allergy and tolerance: bioMarkers and Predictors - CHAMP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015204

Enrollment

2000

Registered

2020-04-14

Start date

2019-10-01

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J45.9 J46 L20 J30.1 K52.2 L27.2 T78.0

Interventions

Group 1: Patients without allergic disease. Patients are asked to fill out questionnaires regarding family history of allergies, environment and quality of life. A variying number of samples is taking

Eligibility

Sex/Gender

All

Age

0 Years to 17 Years

Inclusion criteria

Inclusion criteria: age between 0 and 17 years

Exclusion criteria

Exclusion criteria: age above 17 years

Design outcomes

Primary

Measure	Time frame
Development of molecular biomarkers for occurence of the allergic diseases	—

Secondary

Measure	Time frame
Development of molecular biomarkers for severity and course of the allergic diseases	—

Countries

Germany

Contacts

Public ContactBianca Schaub

Dr. von Haunersches Kinderspital, Ludwig-Maximilian-Universität München

bianca.schaub@med.uni-muenchen.de0049 (0) 89 4400 52857

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026